News & Events
Yes. On July 22, 2021, CMS published the MLN Connects article linked below entitled, “COVID-19: EUA for Tocilizumab Monoclonal Antibody Product”. In the article, CMS announced that 3 new HCPCS codes have been established to report tocilizumab and its associated...
News & Events
Yes. On June 16, 2021, CMS published the MLN Connects article, linked below, that outlines various HCPCS code changes related to Sotrovimab and REGEN-COV COVID-19 monoclonal antibody treatments. On May 26, 2021, the FDA issued an Emergency Use Authorization (EUA) for...
News & Events
Yes. On June 9, 2021, CMS released the MLN Connects Special Edition bulletin linked below, advising that beginning June 8, 2021, CMS will now reimburse providers an additional add-on payment of $35.00 for COVID-19 vaccinations administered to beneficiaries in their...
News & Events
Yes. Through an MLN Connects Special Edition bulletin, CMS announced that effective May 6, 2021, it will be increasing the reimbursement rate paid to providers for COVID-19 monoclonal antibody infusion services from roughly $310 on average, to around $450. Also...
News & Events
Yes. On May 4, 2021, the AMA announced the creation of 3 new CPT codes that will be used to report the Novavax COVID-19 vaccine and its administration. It is extremely important to note that these CPT codes are not yet active. The codes will become effective if and...
News & Events
Yes. On April 16, 2021, the FDA revoked its Emergency Use Authorization (EUA) for Bamlanivimab when administered alone. Per the FDA news release linked below, this decision was rooted in the rise of COVID-19 variants and clinical data which suggests Bamlanivimab is...
